BridgeBio Pharma Inc

BridgeBio Pharma Inc

BBIO

Market Cap$7.92B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BridgeBio Pharma IncBridgeBio Pharma Inc-11.9-41%--
$72.00

Target Price by Analysts

59.6% upsideBridgeBio Pharma Target Price DetailsTarget Price
$-9.00

Current Fair Value

119.9% downside

Overvalued by 119.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$7.92 Billion
Enterprise Value$7.40 Billion
Dividend Yield$0 (0%)
Earnings per Share$-2.88
Beta1.1
Outstanding Shares190,145,253

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-11.88
PEG-3.16
Price to Sales-
Price to Book Ratio-5.01
Enterprise Value to Revenue58.12
Enterprise Value to EBIT-10.98
Enterprise Value to Net Income-12
Total Debt to Enterprise0
Debt to Equity-0.01

Revenue Sources

No data

Insider Trades

ESG Score

No data

About BridgeBio Pharma Inc

CEO: Neil Kumar